Image courtesy of
Warfarin Alternative on the Horizon The FDA is currently evaluating conflictresolvin dabigatran, which appears to offer the same anti-blood clotting benefits of warfarin, but without some of the dangerous side effects. [Consumer Reports Health]
Warfarin Alternative on the Horizon The FDA is currently evaluating conflictresolvin dabigatran, which appears to offer the same anti-blood clotting benefits of warfarin, but without some of the dangerous side effects. [Consumer Reports Health]
Want more consumer news? Visit our parent organization, Consumer Reports, for the latest on scams, recalls, and other consumer issues.
